Chair: Randy Jensen, MD
Co-Chair:  Isaac Yang, MD
Members: Ian Lee, MD, and Wajd Al-Holou, MD

The membership committee continues to work to add value to Tumor Section membership. We personally contacted all Tumor Section members that had not paid their 2023 membership dues. Many members responded to our reminder, and we have significantly improved our number of dues paying members. That said, if you happen fall into this category, please make a little effort to pay those dues and be an up-to-date member of our section.

We continue to adjudicate member survey requests. Each year several surveys are sent to Tumor Section leadership to ask to send surveys to our members. To prevent our members from being continuously inundated with frequent surveys, we want to limit these surveys to only the most important and potentially beneficial for our section. This year, we examined a number of surveys and approved two surveys sent to our members with the spring eblast and had previously approved two different surveys for the fall eblast. Any input from section members would be appreciated.

We continue to explore ways to maximize Tumor Section member benefits and value. We are also thinking of ways to expand our membership to groups that have not been traditionally part of our group. We would appreciate member input on both goals.

We will also assist in helping APPs register for the Tumor Section meeting at a discounted rate by allowing them to use  the “AANS-nonmember APP” function and then join the section as adjunct. Our committee will follow these steps:

1. We will receive a list of the APP applicants and their emails 30 days before each AANS/CNS meeting.
2. We will reach out to their associated AANS provider to confirm that they are APPs.
3. We will submit the list for voting at the EC meeting.